James is a corporate lawyer with over 25 years of experience acting for a wide range of clients. He specialises in public and private M&A and joint ventures whilst also advising on a wide range of other transactions and governance issues.
He has a particular focus on clients in TMT/Digital, Healthcare, Financial Services and Energy.
James spent two years developing his technology expertise whilst working in a technology start-up before returning to Addleshaw Goddard in 2018.
He has advised clients such as Capita, Probo Medical, Sy4Security, NatWest, Heineken, Tiscali and The Economist on M&A transactions.
A selection of transactions that James has advised on include:
- Advising Probo Medical on the acquisition of MIUS International;
- Advising a global commodities trading business on four joint ventures in the renewable energy sector;
- Advising Probo Medical on the acquisition of Future Medical;
- Advising Capita plc on the sale of its employee benefits business to Benefex Financial Solutions;
- Sy4Security on its acquisition of BAe Systems' cyber security business;
- Moore Stephens on the sale of its Rulebook software business to Verisk Inc;
- The Royal Bank of Scotland on the sale of a debt and equity portfolio to Coller/Caird Capital;
- The Royal Bank of Scotland on the sale of its interest in Cairn Capital to Mediobanca;
- The acquisition of the Clermont Leisure (UK) by Mayfair Casinos;
- Alchemy on its acquisition of Hampshire Trust Bank;
- Heineken on its joint venture in Ivory Coast with CFAO;
- The Royal Bank of Scotland on the sale of its Global Treasury Funds business to Goldman Sachs;
- The Economist on the acquisition of TVC;
- Numerous acquisitions of downstream and midstream oil and gas businesses; and
- Tiscali on the sale of its UK business to TalkTalk.
- Joint author of Practical Company Law & Transactions (Sweet & Maxwell)